ATXI vs. SNDK
ATXI (Avenue Therapeutics, Inc.) and SNDK (Sandisk Corporation) are both stocks. ATXI operates in Biotechnology (Healthcare), while SNDK operates in Computer Hardware (Technology). Over the past year, ATXI returned 0.42% vs 4781.34% for SNDK. At a correlation of -0.05, they often move in opposite directions.
Performance
ATXI vs. SNDK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ATXI achieves a -55.90% return, which is significantly lower than SNDK's 857.84% return.
ATXI
- 1D
- -7.85%
- 1M
- 24.54%
- YTD
- -55.90%
- 6M
- -53.99%
- 1Y
- 0.42%
- 3Y*
- -84.76%
- 5Y*
- -83.83%
- 10Y*
- —
SNDK
- 1D
- 4.07%
- 1M
- 53.77%
- YTD
- 857.84%
- 6M
- 843.26%
- 1Y
- 4,781.34%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ATXI vs. SNDK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
ATXI Avenue Therapeutics, Inc. | -55.90% | -49.99% |
SNDK Sandisk Corporation | 857.84% | 356.50% |
Correlation
The correlation between ATXI and SNDK is -0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.10 |
Correlation (All Time) Calculated using the full available price history since Feb 24, 2025 | -0.05 |
Fundamentals
ATXI:
$988.12K
SNDK:
$356.98B
ATXI:
-$0.55
SNDK:
$29.70
ATXI:
0.68
SNDK:
26.17
ATXI:
0.82
SNDK:
25.91
ATXI:
$1.40M
SNDK:
$13.18B
ATXI:
$0.00
SNDK:
$7.39B
ATXI:
-$2.06M
SNDK:
$5.37B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ATXI vs. SNDK — Risk / Return Rank
ATXI
SNDK
ATXI vs. SNDK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Avenue Therapeutics, Inc. (ATXI) and Sandisk Corporation (SNDK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ATXI | SNDK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -48.44 | ||
| Sortino ratioReturn per unit of downside risk | -6.54 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 2.15 | -0.89 |
| Calmar ratioReturn relative to maximum drawdown | 0.01 | 155.00 | -155.00 |
| Martin ratioReturn relative to average drawdown | 0.01 | 468.86 | -468.85 |
Loading charts...
Drawdowns
ATXI vs. SNDK - Drawdown Comparison
The maximum ATXI drawdown since its inception was -100.00%, which is greater than SNDK's maximum drawdown of -47.50%. Use the drawdown chart below to compare losses from any high point for ATXI and SNDK.
Loading charts...
Drawdown Indicators
| ATXI | SNDK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -47.50% | -52.50% |
Max Drawdown (1Y)Largest decline over 1 year | -83.80% | -31.34% | -52.46% |
Max Drawdown (3Y)Largest decline over 3 years | -99.83% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -99.99% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | 0.00% | -100.00% |
Average DrawdownAverage peak-to-trough decline | -70.79% | -13.57% | -57.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.66% | 10.34% | +34.32% |
Volatility
ATXI vs. SNDK - Volatility Comparison
Avenue Therapeutics, Inc. (ATXI) has a higher volatility of 71.29% compared to Sandisk Corporation (SNDK) at 28.09%. This indicates that ATXI's price experiences larger fluctuations and is considered to be riskier than SNDK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ATXI | SNDK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 71.29% | 28.09% | +43.20% |
Volatility (6M)Calculated over the trailing 6-month period | 167.86% | 70.78% | +97.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 227.85% | 100.47% | +127.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 180.36% | 97.66% | +82.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 145.73% | 97.66% | +48.07% |
Dividends
ATXI vs. SNDK - Dividend Comparison
Neither ATXI nor SNDK has paid dividends to shareholders.
Financials
ATXI vs. SNDK - Financials Comparison
This section allows you to compare key financial metrics between Avenue Therapeutics, Inc. and Sandisk Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ATXI and SNDK have a correlation of -0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ATXI has higher volatility (71.29%) compared to SNDK (28.09%). In terms of maximum drawdown, ATXI dropped -100.00% vs SNDK's -47.50%.
SNDK currently has the higher Sharpe Ratio (48.44 vs 0.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ATXI and SNDK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer